HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)

CUSIP: 427746102

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
+9,850,769
Put/Call ratio
5.6%
SEC-reported price per share
$2.20
Number of holders
164
Value change
+$21,979,195
Number of buys
74
Open additional details 1 more signal available
Number of sells
63
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
182,615,507

Security key

427746102

Report period

Q1 2025

Institutions

164

Top holders

10

Ownership snapshot

Top reported holders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Rubric Capital Management LP
Disclosed value leader
Rubric Capital Management LP
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F 3/4/5 Lead comparable stake: 15% Showing 1-6 of 15 holder rows.

Quick read

Rubric Capital Management LP leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Rubric Capital Management LP's linked filing trail.
Comparable ownership Top 5
Rubric Capital Management LP 15%
BlackRock, Inc. 4.7%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4.7%
VANGUARD GROUP INC 4.5%
Velan Capital Investment Manageme... 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Rubric Capital Management LP
13F
Company
13F
15%
$40,871,660
26,713,503 shares
31 Dec 2024
BlackRock, Inc.
13F
Company
13F
4.7%
$13,143,836
8,590,742 shares
31 Dec 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
4.7%
$13,005,000
8,500,000 shares
31 Dec 2024
VANGUARD GROUP INC
13F
Company
13F
4.5%
$12,481,142
8,157,609 shares
31 Dec 2024
Velan Capital Investment Management LP
13F 3/4/5
Company · Other*
3.8%
$10,689,718
6,986,744 shares
31 Dec 2024
Tejara Capital Ltd
13F
Company
13F
2.6%
$7,132,167
4,661,547 shares
31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
164
Shares
124,770,231
Rows available
164
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders
164
Q1 2025 holders
164
Holder diff
0
Investor Q1 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2025 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .